Chargement en cours...
Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab
Plitidepsin (Aplidin), an antitumor agent of marine origin, presently is undergoing phase II/III clinical trials, and has shown promise for the treatment of lymphoma. Here, we describe the antitumor effects of plitidepsin alone and in combination with rituximab and investigated the effects of each d...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Landes Bioscience
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3336068/ https://ncbi.nlm.nih.gov/pubmed/22336911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.13.2.18876 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|